Less Is More: Hypofractionation for Equitable and Sustainable Cancer Care
- 1 October 2025
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 11 (11) , e2500153
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Investigating the Uptake of Hypofractionation for Breast and Prostate Cancer in Sub-Saharan Africa: A Qualitative Study of Physician and Medical Physicist PerspectivesAdvances in Radiation Oncology, 2024
- Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic ReviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
- Effect of Radiation Schedule on Transportation-Related Carbon Emissions: A Case Study in Rectal CancerAdvances in Radiation Oncology, 2023
- Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and OlderInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Targeting Education as a Barrier to Implement Hypofractionation: Results of a Country-Wide Training ProgramAdvances in Radiation Oncology, 2022
- The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium ReportClinical Oncology, 2021
- Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income LevelClinical Oncology, 2017
- ReCiPe2016: a harmonised life cycle impact assessment method at midpoint and endpoint levelThe International Journal of Life Cycle Assessment, 2016
- Potential for Information and Communication Technologies to Catalyze Global Collaborations in Radiation OncologyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014